Most vaccines have traditionally been administered to infants and young children, but maternal vaccination has received increasing attention as a means of protecting both mother and child. This talk looks at factors driving the value of maternal vaccination, such as protection to the mother, duration of protection for the infant and seasonality. Examples will be drawn from cost-effectiveness analyses used to inform policy in the United Kingdom as well as in low and middle-income countries, for both existing vaccines like seasonal influenza vaccines as well as pipeline vaccines like RSV and GBS vaccines.
About Professor Mark Jit
Mark Jit is professor of vaccine epidemiology at the London School of Hygiene & Tropical Medicine, principal scientist in the Modelling and Economics Unit of Public Health England and visiting professor at the School of Public Health, University of Hong Kong. His research group focuses on epidemiological and economic modelling of vaccines to support evidence-based public health decision making. He has published papers covering a range of antigens including measles, HPV, pneumococcus, rotavirus, influenza, dengue, EV71 and RSV as well as methodological papers advancing the ways vaccines are evaluated.